Published in Cancer Weekly, January 15th, 2002
The study was performed by scientists at the University of California, San Diego (UCSD) School of Medicine, in conjunction with colleagues from Lund University in Sweden.
The research team, led by Jeffrey D. Esko, PhD, professor of Cellular and Molecular Medicine and associate director of the UCSD Glycobiology Research and Training Center, reports that tumor growth was blocked in vitro and in laboratory mice by interfering with a cell's ability to supply itself with vital substances...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.